U-Blot® Research Grade Anti-Human PCSK9 (MEDI4166)Cat. No. WA2164$9,999
Size: 50ug/100ug
Biosimilar antibodies are developed strictly against reference therapeutic mAbs. Validated through multi-dimensional physicochemical, functional and clinical studies, they exhibit highly consistent efficacy and safety profiles compared with originator products, featuring cost advantages and stable lot-to-lot quality.
U-Blot® Research Grade Anti-Human PCSK9 (MEDI4166)Cat. No. WA2164
U-Blot® Research Grade Anti-Human PCSK9 (GM-0023)Cat. No. WA2163
U-Blot® Research Grade Anti-Human PCSK9 (B1655)Cat. No. WA2162
U-Blot® Research Grade Anti-Human PCSK9 (ALD306)Cat. No. WA2161
U-Blot® Research Grade Anti-Human PACAP38 Antibody (Ab22)Cat. No. WA2160
U-Blot® Research Grade Anti-Human OSM/Oncostatin-M (GSK315234)Cat. No. WA2159
U-Blot® Research Grade Anti-Human OSM/Oncostatin-M (GSK 2330811)Cat. No. WA2158
U-Blot® Research Grade Anti-Human OPN/SPP1 (ASK8007)Cat. No. WA2157
U-Blot® Research Grade Anti-Human NTRK1/TRKA (MNAC13)Cat. No. WA2156
U-Blot® Research Grade Anti-Human NTRK1/TRKA (GBR 900)Cat. No. WA2155
U-Blot® Research Grade Anti-Human NTN1/Netrin-1 (NP137)Cat. No. WA2154
U-Blot® Research Grade Anti-Human NRG1/Neuregulin-1 (JK07)Cat. No. WA2153